| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |